BC
DVAX

Bartlett & Co’s Dynavax Technologies DVAX Stock Holding History

Bartlett & Co’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$50K Buy
+3,500
New +$48.6K ﹤0.01% 706

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Bartlett & Co's DVAX Position: Q4 2023 in Review

Bartlett & Co opened a new position in Dynavax Technologies (DVAX) in Q4 2023: 3,500 shares worth $50K. The stake represents ﹤0.01% of the portfolio and ranks #706 among its holdings.

246 funds tracked by Wall St. Rank hold DVAX as of Q4 2023.

  • Bartlett & Co held 3,500 shares of Dynavax Technologies worth $50K as of Q4 2023.
  • Dynavax Technologies was a new Bartlett & Co position in Q4 2023.
  • Dynavax Technologies made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #706 holding.
  • 246 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.